These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28719027)

  • 1. Marker of coxsackievirus-B4 infection in saliva of patients with type 1 diabetes.
    Badia-Boungou F; Sane F; Alidjinou EK; Ternois M; Opoko PA; Haddad J; Stukens C; Lefevre C; Gueorguieva I; Hamze M; Ismail M; Weill J; Monabéka HG; Bouenizabila E; Moukassa D; Abena AA; Hober D
    Diabetes Metab Res Rev; 2017 Oct; 33(7):. PubMed ID: 28719027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary anti-coxsackievirus-B4 neutralizing activity and pattern of immune parameters in patients with type 1 diabetes: a pilot study.
    Nekoua MP; Yessoufou A; Alidjinou EK; Badia-Boungou F; Moutairou K; Sane F; Hober D
    Acta Diabetol; 2018 Aug; 55(8):827-834. PubMed ID: 29774468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing and neutralizing anti-coxsackievirus activities in serum samples from patients prior to development of type 1 diabetes.
    Sane F; Bertin A; Sioofy-Khojine AB; Oikarinen S; Alidjinou EK; Veijola R; Toppari J; Ilonen J; Knip M; Engelmann I; Hyöty H; Hober D
    Diabetes Metab Res Rev; 2020 Sep; 36(6):e3305. PubMed ID: 32118346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunology in the clinic review series; focus on type 1 diabetes and viruses: role of antibodies enhancing the infection with Coxsackievirus-B in the pathogenesis of type 1 diabetes.
    Hober D; Sane F; Jaïdane H; Riedweg K; Goffard A; Desailloud R
    Clin Exp Immunol; 2012 Apr; 168(1):47-51. PubMed ID: 22385236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin G-dependent enhancement of the infection with Coxsackievirus B4 in a murine system.
    Elmastour F; Jaidane H; Aguech-Oueslati L; Benkahla MA; Aouni M; Gharbi J; Sane F; Hober D
    Virulence; 2016 Jul; 7(5):527-35. PubMed ID: 27030584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enterovirus infections with beta-cell tropic strains are frequent in siblings of children diagnosed with type 1 diabetes children and in association with elevated levels of GAD65 antibodies.
    Frisk G; Tuvemo T
    J Med Virol; 2004 Jul; 73(3):450-9. PubMed ID: 15170642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody capture radioimmunoassay (MACRIA) for coxsackievirus B4 and B5-specific IgM.
    Morgan-Capner P; McSorley C
    J Hyg (Lond); 1983 Jun; 90(3):333-49. PubMed ID: 6306097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A part of the VP4 capsid protein exhibited by coxsackievirus B4 E2 is the target of antibodies contained in plasma from patients with type 1 diabetes.
    Sauter P; Chehadeh W; Lobert PE; Lazrek M; Goffard A; Soumillon M; Caloone D; Vantyghem MC; Weill J; Fajardy I; Alm G; Lucas B; Hober D
    J Med Virol; 2008 May; 80(5):866-78. PubMed ID: 18366069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enteroviruses and type 1 diabetes: towards a better understanding of the relationship.
    Jaïdane H; Sauter P; Sane F; Goffard A; Gharbi J; Hober D
    Rev Med Virol; 2010 Sep; 20(5):265-80. PubMed ID: 20629044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 1 diabetes and Coxsackie virus infection.
    Di Pietro C; Del Guercio MJ; Paolino GP; Barbi M; Ferrante P; Chiumello G
    Helv Paediatr Acta; 1979; 34(6):557-61. PubMed ID: 232095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human milk can neutralize Coxsackievirus B4 in vitro.
    Sane F; Alidjinou EK; Kacet N; Moukassa D; Charlet C; Ebatetou-Ataboho E; Ngoulou W; Badia-Boungou F; Romond MB; Hober D
    J Med Virol; 2013 May; 85(5):880-7. PubMed ID: 23408519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serologic prevalence of coxsackievirus group B in Greece.
    Mavrouli MD; Spanakis N; Levidiotou S; Politi C; Alexiou S; Tseliou P; Hatzitaki M; Foundouli K; Tsakris A; Legakis NJ; Routsias JG
    Viral Immunol; 2007; 20(1):11-8. PubMed ID: 17425417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic beta cells persistently infected with coxsackievirus B4 are targets of NK cell-mediated cytolytic activity.
    Nekoua MP; Bertin A; Sane F; Alidjinou EK; Lobert D; Trauet J; Hober C; Engelmann I; Moutairou K; Yessoufou A; Hober D
    Cell Mol Life Sci; 2020 Jan; 77(1):179-194. PubMed ID: 31172216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of coxsackievirus B4 in the pathogenesis of type 1 diabetes.
    Jaïdane H; Hober D
    Diabetes Metab; 2008 Dec; 34(6 Pt 1):537-48. PubMed ID: 18951821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coxsackievirus B4 as a Causative Agent of Diabetes Mellitus Type 1: Is There a Role of Inefficiently Treated Drinking Water and Sewage in Virus Spreading?
    El-Senousy WM; Abdel-Moneim A; Abdel-Latif M; El-Hefnawy MH; Khalil RG
    Food Environ Virol; 2018 Mar; 10(1):89-98. PubMed ID: 29022248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-coxsackievirus B4 (CV-B4) enhancing activity of serum associated with increased viral load and pathology in mice reinfected with CV-B4.
    Elmastour F; Jaïdane H; Benkahla M; Aguech-Oueslati L; Sane F; Halouani A; Engelmann I; Bertin A; Mokni M; Gharbi J; Aouni M; Alidjinou EK; Hober D
    Virulence; 2017 Aug; 8(6):908-923. PubMed ID: 27792461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced Coxsackie antibody titres in type 1 (insulin-dependent) diabetic patients presenting during an outbreak of Coxsackie B3 and B4 infection.
    Palmer JP; Cooney MK; Ward RH; Hansen JA; Brodsky JB; Ray CG; Crossley JR; Asplin CM; Williams RH
    Diabetologia; 1982 Jun; 22(6):426-9. PubMed ID: 6286394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Contamination Risks with Coxsackievirus B4 E2 in Swiss Albino Mice Stools.
    Aguech-Oueslati L; Jaidane H; Sane F; Jrad-Battikh N; Hamed SB; Hober D; Gharbi J
    Curr Microbiol; 2018 Jan; 75(1):32-39. PubMed ID: 28856411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virus antibody survey in different European populations indicates risk association between coxsackievirus B1 and type 1 diabetes.
    Oikarinen S; Tauriainen S; Hober D; Lucas B; Vazeou A; Sioofy-Khojine A; Bozas E; Muir P; Honkanen H; Ilonen J; Knip M; Keskinen P; Saha MT; Huhtala H; Stanway G; Bartsocas C; Ludvigsson J; Taylor K; Hyöty H;
    Diabetes; 2014 Feb; 63(2):655-62. PubMed ID: 24009257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibody levels against coxsackie B viruses in patients with type 1 diabetes mellitus].
    Emekdaş G; Rota S; Kuştimur S; Kocabeyoğlu O
    Mikrobiyol Bul; 1992 Apr; 26(2):116-20. PubMed ID: 1316989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.